You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The German hospital will build interpretation and reporting on the PierianDx Clinical Genomics Workspace for two Illumina assays.
The company offers products and services for analyzing, interpreting, and reporting clinical next-generation sequencing data with a focus on cancer.
Data from MMRF's Immune Atlas will be included in its recently launched CureCloud, a registry of clinical, genomic, and EHR data from multiple myeloma patients.
The company also said it has been awarded a research sequencing grant from Illumina Accelerator.
The former cofounder of Knome believes that the future of precision medicine lies in our ability to program living things to act as medicines.
The companies will integrate PierianDx's informatics solution with two of Illumina's NGS cancer research panels and as well as future IVD products.
Allscripts subsidiary 2bPrecise will work with startup PierianDx to combine NGS and clinical data as they seek to advance precision care for cancer patients.
Malaysia-based ScienceVision has agreed to commercialize and distribute the PierianDx Clinical Genomics Workspace platform in Southeast Asian countries.
The firms will work to accelerate the adoption of PierianDx's genomics platform for translating data into patient-specific diagnoses and treatments.
The companies will join their respective technologies into a precision oncology testing and analysis offering.
In a new ruling, Canada's Supreme Court upheld the country's genetic non-discrimination law, the Canadian Press reports.
Nature News reports on how meeting cancellations and related costs are affecting scientific societies.
COVID-19 vaccine developers aim to avoid a complication that has affected efforts to develop vaccines for other diseases, the Wall Street Journal reports.
In PLOS this week: analysis of insertions throughout Shigella genomes, antigen production in malaria parasites, and more.